Last update 01 Nov 2024
CMD-EO05
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with CMD-EO05一项评估CMDE005在EGFR阳性晚期实体瘤患者中安全性、药代动力学特征和有效性的单臂、开放性、多中心的I/IIa期临床研究
[Translation] A single-arm, open-label, multicenter Phase I/IIa clinical study to evaluate the safety, pharmacokinetic characteristics and efficacy of CMDE005 in patients with EGFR-positive advanced solid tumors
An Open-Label, Phase 1/2a, Single-Arm Study Assessing the Safety, Pharmacokinetics and Efficacy of CMDE005 in Patients with EGFR-Positive Advanced Solid Tumors
100 Clinical Results associated with CMD-EO05
Login to view more data
100 Translational Medicine associated with CMD-EO05
Login to view more data
100 Patents (Medical) associated with CMD-EO05
Login to view more data
100 Deals associated with CMD-EO05
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| EGFR mutation Solid Tumors | Phase 1 | CN | 08 Oct 2024 | |
| Solid tumor | Preclinical | CN | 12 Oct 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free